Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Aktionär | Typ | Gehalten (Tatsächlich) | % Ausstehender Aktien | Marktwert | Positionsdatum |
|---|---|---|---|---|---|
| Frazier Life Sciences Management, LP | Institution | 6.652.013 | 13,98% | US$ 199,89M | 2026-03-31 |
| Frazier Life Sciences X, L.P. | Institution | 5.219.440 | 10,97% | US$ 156,84M | 2025-09-26 |
| OrbiMed Advisors LLC | Institution | 3.637.887 | 7,64% | US$ 109,32M | 2026-03-31 |
| New Enterprise Associates, Inc. | Institution | 3.614.486 | 7,59% | US$ 108,62M | 2026-03-31 |
| New Enterprise Associates 17, L.P. | Institution | 3.614.486 | 7,59% | US$ 108,62M | 2025-11-10 |
| Wellington Management Group LLP | Institution | 3.191.824 | 6,71% | US$ 95,91M | 2026-03-31 |
| Orbimed Private Investments VII, LP | Institution | 2.958.000 | 6,21% | US$ 88,89M | 2026-02-11 |
| BlackRock, Inc. | Institution | 2.941.406 | 6,18% | US$ 88,39M | 2026-03-31 |
| FMR LLC | Institution | 2.936.684 | 6,17% | US$ 88,25M | 2026-03-31 |
| Deep Track Capital, LP | Institution | 2.757.569 | 5,79% | US$ 82,86M | 2026-03-31 |
| Deep Track Biotechnology Master Fund, Ltd | Institution | 2.188.592 | 4,60% | US$ 65,77M | 2025-06-30 |
| Norwest Venture Partners XVI, LP. | Institution | 2.136.335 | 4,49% | US$ 64,20M | 2025-09-26 |
| NVP Associates, LLC | Institution | 2.136.335 | 4,49% | US$ 64,20M | 2026-03-31 |
| Wellington Biomedical Innovation Master Investors (Cayman) II L.P. | Institution | 2.017.394 | 4,24% | US$ 60,62M | 2025-09-30 |
| Polar Capital Holdings Plc | Institution | 1.622.186 | 3,41% | US$ 48,75M | 2026-03-31 |
| Braidwell LP | Institution | 1.492.467 | 3,14% | US$ 44,85M | 2026-03-31 |
| Vanguard Capital Management, LLC | Institution | 1.477.592 | 3,10% | US$ 44,40M | 2026-03-31 |
| Mr. Peter Hawryluk | Insider | 1.214.444 | 2,55% | US$ 36,49M | 2026-05-06 |
| Aaron Wealth Advisors LLC | Institution | 1.168.176 | 2,45% | US$ 35,10M | 2026-03-31 |
| Cormorant Asset Management, LP | Institution | 1.120.000 | 2,35% | US$ 33,66M | 2026-03-31 |
| Frazier Life Sciences Public Fund, L.P. | Institution | 1.103.920 | 2,32% | US$ 33,17M | 2025-09-26 |
| T. Rowe Price Group, Inc. | Institution | 1.029.007 | 2,16% | US$ 30,92M | 2026-03-31 |
| Driehaus Capital Management LLC | Institution | 1.018.212 | 2,14% | US$ 30,60M | 2026-03-31 |
| Kynam Capital Management, LP | Institution | 934.799 | 1,96% | US$ 28,09M | 2026-03-31 |
| Citadel Advisors LLC | Institution | 932.833 | 1,96% | US$ 28,03M | 2026-03-31 |
| Woodline Partners LP | Institution | 900.063 | 1,89% | US$ 27,05M | 2026-03-31 |
| Eventide Asset Management, LLC | Institution | 890.000 | 1,87% | US$ 26,74M | 2026-03-31 |
| Caligan Partners, LP | Institution | 848.590 | 1,78% | US$ 25,50M | 2026-03-31 |
| Parkman Healthcare Partners LLC | Institution | 800.037 | 1,68% | US$ 24,04M | 2026-03-31 |
| State Street Global Advisors, Inc. | Institution | 787.208 | 1,65% | US$ 23,66M | 2026-03-31 |
| EcoR1 Capital, LLC | Institution | 777.000 | 1,63% | US$ 23,35M | 2026-03-31 |
| OrbiMed Genesis Master Fund, L.P. | Institution | 679.887 | 1,43% | US$ 20,43M | 2026-02-11 |
| Geode Capital Management, LLC | Institution | 670.385 | 1,41% | US$ 20,15M | 2026-03-31 |
| TCG Crossover Management, LLC | Institution | 650.000 | 1,37% | US$ 19,53M | 2026-03-31 |
| Millennium Management LLC | Institution | 564.415 | 1,19% | US$ 16,96M | 2026-03-31 |
| StemPoint Capital LP | Institution | 499.469 | 1,05% | US$ 15,01M | 2026-03-31 |
| The Goldman Sachs Group, Inc. | Institution | 425.546 | 0,89% | US$ 12,79M | 2026-03-31 |
| UBS Asset Management AG | Institution | 354.152 | 0,74% | US$ 10,64M | 2026-03-31 |
| Frazier Life Sciences Public Overage Fund, L.P. | Institution | 325.653 | 0,68% | US$ 9,79M | 2025-09-26 |
| Candriam, Société En Commandite Par Actions | Institution | 294.374 | 0,62% | US$ 8,85M | 2026-03-31 |
| Vanguard Portfolio Management, LLC | Institution | 293.295 | 0,62% | US$ 8,81M | 2026-03-31 |
| D. E. Shaw & Co., L.P. | Institution | 288.889 | 0,61% | US$ 8,68M | 2026-03-31 |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
